Methods This retrospective real-world study evaluated 106 adults aged 1875 years with newly diagnosed T2D who initiated semaglutide (1.0 mg) or dulaglutide (1.5 mg) between December 2023 and December 2024
Drucker commented: GLP1 [drugs] have given us so many wonderful results, but tackling these very challenging brain disorders has been disappointing There was a hope that we would see some benefit, and we didnt. From the Alzheimers Drug Discovery Foundation (ADDF), Howard Fillit, MD, emphasized that even negative trials move the field forward, pointing to the need to target the broader pathobiology of Alzheimers and to consider preventive or combination approaches informed by biomarker profiles
This serum is hypoallergenic, free from parabens, sulfates, alcohol, and essential oils, and is gentle enough for daily use
Choosing by Goal, Not by Comfort Level People often pick topical because needles are unpleasant and creams are easy